Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • casual_seqs
    Junior Member
    • Jun 2009
    • 5

    Adaptor technologies comparison

    Hello,

    I am interested in the comparison/respective advantages and weak points of the various adapters technologies, from the point of view of in-vitro genomic libraries construction and amplification, the avoidance of artifacts, and ease of preparation.

    1°) Comments of users with a global view on this (including the adapter technologies of Solexa, Illumina, Solid, etc...) ?
    I am interested in the details also (eventual exo protection, eventual 3'-end and/or 5'-end modification, etc...)

    2°) Alternatly, I would welcome comments of users with hands-on experience with their particular library preps, regarding the avoidance of artifacts, and ease of preparation, and structures of the oligos.

    3°) about the Solid adaptors: (see also http://seqanswers.com/forums/showthread.php?t=588)

    I have read in the forum (http://seqanswers.com/forums/showthread.php?t=198, sci_guy), that the solid adaptors are non-phosphorylated, so that P1-P1, P2-P2, or P1-P2 dimers are not formed at the ligation step; (by the way, are the 3'TT-overhangs efficient at avoiding ligation to genomic DNA ?)
    Also, for the amplification steps, the targets of the primers are generated by nick translation.
    Those features appears clever; Does this technique readily outperforms the competitor's adapters technologies ?


    note: I transferred the initial post http://seqanswers.com/forums/showthread.php?t=1944, to this forum.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
38 views
0 reactions
Last Post SEQadmin2  
Working...